Old Web
English
Sign In
Acemap
>
authorDetail
>
Evis Havari
Evis Havari
Sanofi S.A.
Medicine
Alemtuzumab
Immunology
Neurofilament
Internal medicine
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A novel cell type negatively associated with secondary autoimmunity in alemtuzumab-treated patients is revealed through single-cell longitudinal analysis of clinical trial samples
2021
medRxiv
Virginia Savova
Richa Hanamsagar
Mathew Chamberlain
Srinivas Shankara
Robert Marcus
Darren P. Baker
Klinger Kw
Evis Havari
Frank Nestle
Emanuele de Rinaldis
Show All
Source
Cite
Save
Citations (0)
Central Effects of BTK Inhibition in Neuroinflammation (808)
2020
Neurology
Ross C. Gruber
Nathalie Chretien
Michael R. Dufault
Jonathan Proto
Mindy Zhang
Michael LaMorte
Evis Havari
Tarek A Samad
Timothy Turner
Anthony Chomyk
Emilie Christie
Bruce D. Trapp
Dimitry Ofengeim
Show All
Source
Cite
Save
Citations (0)
Alemtuzumab Treatment Reduces Serum Neurofilament to Levels Comparable With Healthy Controls More Effectively Than SC IFNb-1a: CARE-MS I
2019
Evis Havari
Nadia Daizadeh
Christian Barro
Zuzanna Michalak
David Leppert
Jean Godin
Srinivas Shankara
Luke Chung
Nora Roesch
Carina Kaiser
Tarek A Samad
Alan Jacobs
Ludwig Kappos
Jens Kuhle
Show All
Source
Cite
Save
Citations (0)
1